A 12-year-old boy currently is followed by multiple subspecialists for problems caused by the chromosome 22q11.2 deletion syndrome (22q11DS) (Figure) . He was born via spontaneous vaginal delivery, weighing 3033 g, to a 31-year-old G3P3 mother after a full-term pregnancy complicated only by mild polyhydramnios. Family history was non-contributory. Apgar scores were 8 at 1 minute and 9 at 5 minutes. With the exception of a weak cry, the results of the infant's initial examination were unremarkable, and he was moved to the well-baby nursery. Shortly thereafter, a cardiac murmur was noted, the cardiology department was consulted, and the child was transferred to a local tertiary care facility with a diagnosis of tetralogy of Fallot. Stable, he was discharged home at 3 days of life.
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At 5 days of life, he had jerky movements. On presentation to the local emergency department, his total calcium level was 4.7 mg/dL, and later partial hypoparathyroidism was diagnosed. At that time, a consulting geneticist suggested the diagnosis of chromosome 22q11DS. Weeks later, the family received a telephone call confirming the diagnosis with fluorescence in situ hybridization (FISH) . No additional information about the diagnosis, prognosis, etiology, or recurrence risk was provided until the child was 5 months of age, when he underwent cardiac repair at a third hospital, where a comprehensive 22q11DS program was in operation. In the interim, the child had feeding difficulties requiring supplemental nasogastric tube feeds, nasal regurgitation, and gastroesophageal reflux, while the parents searched the internet for reliable information about their son's diagnosis.
Subsequent notable abnormalities and interventions included: recurrent otitis media with bilateral myringotomy tube placement at 6 months; angioplasty with left pulmonary artery stent placement after the identification of pulmonary artery stenosis with bilateral pleural effusions at age 6 years; chronic upper respiratory infections with significant T cell dysfunction requiring live viral vaccines to be held until age 7 years; velopharyngeal incompetence necessitating posterior pharyngeal flap surgery at 7 years; enamel hypoplasia and numerous caries resulting in 3 separate dental procedures under general cardiac anesthesia beginning at age 7 years; multiple cervical and thoracic vertebral anomalies with thoracic levoconvex scoliosis and upper lumbar dextroscoliosis requiring growing rod placement at age 11 years with subsequent rod extension at ages 11.5 and 12 years; postoperative hypocalcemia; short stature; constipation; and persistent idiopathic thrombocytopenia. Pertinent negative test results included normal renal ultrasound scanning and parental 22q11.2 deletion studies.
On physical examination, the boy's height and weight have consistently tracked just below the fifth percentile, with no evidence of growth hormone deficiency. His head circumference is within reference range at the 25th percentile. Dysmorphic features include: a low anterior hairline; hooded eyelids; malar flatness; normally formed but protuberant ears with attached lobes; a mildly deviated nose with a bulbous nasal tip and hypoplastic alae nasi; asymmetric crying facies with a thin upper lip; mild micrognathia; a sacral dimple; and soft tissue syndactyly of the second and third toes.
Developmentally, the boy had mild delays in achieving motor milestones, sitting at 11 months and walking at 18 months. However, he exhibited significant delays in the emergence of language: he never babbled, spoke his first words at age 3 years, and only achieved full conversational speech at 7 years. However, he had relative strengths in receptive language and communicated appropriately by the use of sign language. Now quite conversant, he is mainstreamed in the seventh grade with resource room supports. Moreover, he is affable, but exhibits anxiety and perseverations. Lastly, despite numerous medical, academic, and social challenges, he participates in assisted athletics, is an avid wrestling fan, and enjoys travel. However, his exceptionally supportive parents, siblings, and extended family continue to worry about his long-term outcome and transition of care as he approaches adulthood. As demonstrated by this boy's complicated course, practical multi-system guidelines are needed to assist the general practitioner and specialists in caring for patients with 22q11DS. Although still under-recognized, detection, including in the prenatal setting, is increasing. Moreover, the phenotypic spectrum is highly variable, and patients may present at any age. Thus, initial guidelines developed by an international panel of experts present the best practice recommendations currently available across the lifespan, with a major focus on the changing issues through childhood development.
Background
Although clinically under-recognized, 22q11DS is the most common microdeletion syndrome (MIM #188400/#192430), with an estimated prevalence of 1 in 4000 live births. [1] [2] [3] However, the actual occurrence may be higher because of variable expressivity. 4 In comparison, Down syndrome is seen in 1 in 1200 newborns. 5 The 22q11.2 deletion is the second most common cause of developmental delay and major congenital heart disease after Down syndrome, accounting for approximately 2.4% of individuals with developmental disabilities 6 and approximately 10% to 15% of patients with tetralogy of Fallot. 7, 8 22q11.2 deletions have been identified in most patients with DiGeorge syndrome, velocardiofacial syndrome, and conotruncal anomaly face syndrome [9] [10] [11] [12] [13] [14] and in a subset with autosomal dominant Opitz G/BBB syndrome and Cayler cardiofacial syndrome. 15, 16 Although this list of associated disorders may appear quite perplexing, it is understandable because the diagnoses were originally described by clinicians concentrating on their particular areas of interest. After the widespread use of FISH, however, patients with a deletion became collectively referred to by their chromosomal etiology: the 22q11.2DS.
Clinical features prompting a clinician to perform 22q11.2 deletion studies may vary depending on the age of the patient. However, they commonly include two or more of these classic findings: developmental disabilities, learning disabilities, or both [17] [18] [19] ; conotruncal cardiac anomalies, palatal defects, nasal regurgitation, and/or hypernasal speech; behavioral problems, psychiatric illness, or both 20, 21 ; immunodeficiency 22 ; hypocalcemia; and characteristic facial features ( Figure) . [23] [24] [25] [26] However, because of the significant variability of expression, especially in the absence of classic findings, the diagnosis may be missed. 34, 35 This variable expression also means that 22q11.2 deletions may be detected in patients in whom other clinical syndromes were previously diagnosed, such as Goldenhar for example. 4 Identification of 22q11DS, especially in adolescents and adults, often requires an enhanced index of suspicion. [23] [24] [25] Male and female children are equally affected. 26 The hemizygous 22q11.2 deletion (ie, on only one of the chromosome pair) is almost always too small to be identified with cytogenetic studies using standard chromosome banding techniques alone. Since 1992, FISH studies, with probes such as N25 or TUPLE1 within the most commonly deleted region, have allowed clinical laboratories to identify patients with submicroscopic 22q11.2 deletions. Most patients (approximately 85%) have a large (approximately 3 Mb) deletion, encompassing approximately 45 functional genes, whereas the remaining patients have smaller atypical or ''nested'' deletions, usually within the 3 Mb deletion region. 27, 28 FISH is limited to one single target sequence within the proximal 22q11.2 deletion region. Some ''atypical'' deletions do not include the region containing FISH probes generally used for clinical testing, 29 thus patients studied only with these methods would remain undetected. More sophisticated techniques that can detect 22q11.2 deletions of any size, such as array comparative genomic hybridization (aCGH), genome-wide microarrays and multiplex ligationdependent probe amplification (MLPA), will eventually replace FISH studies in most laboratories. 30 The occurrence of 22q11.2 deletions is related to the genomic architecture of the chromosome 22q11.2 region. Low copy repeat (LCR) sequences with high homology to each other make this region especially susceptible to 31 These LCR sequences flank the common 22q11.2 deletions and define the common breakpoints. Breakpoints that are not flanked by LCRs, however, may involve other repeat elements and mechanisms that are yet to be defined. 32, 33 Most 22q11.2 deletions (>90%) are found to have arisen as de novo (spontaneous) events, with both parents unaffected. 4, 28 However, in as many as 10% of individuals, a 22q11.2 deletion is identified in a parent, approximately equally in mothers and fathers. 28, 34 Therefore, on the basis of the significant variability of expression and somatic mosaicism (the deletion is present only in a subset of tissues; eg, lymphocytes), 39 parental testing is recommended for all, with appropriate follow-up and genetic counseling when a deletion is identified. 4, 35 Considering mortality, unlike the early reports of patients with DiGeorge syndrome, with improved palliative cardiac repair and medical management of immunodeficiency, infant mortality in 22q11DS is now relatively low (approximately 4%). 34 However, compared with population-based expectations, the overall mortality rate is elevated, especially in adults. 42 22q11DS is quintessentially a multi-system syndrome with a remarkable variability in the severity and extent of expression in individuals, 35 even in affected members of the same family. 34 Moreover, the presence of one feature does not predict the presence of any other feature. Also, to date there are no convincing data indicating major differences in clinical expression related to the variable size and extent of the 22q11.2 deletions. 4, 28 Thus, although there are some recommendations that are relevant for all patients, treatment must be targeted to best suit the individual, their age or developmental stage, and their particular constellation of associated features, severity, and need for treatment. For example, as seen in our illustrative case report, in infancy and preschool classic features such as any combination of feeding problems, infection, hypocalcemia, and structural cardiac and palatal anomalies may be accompanied by speech, learning, and/or developmental difficulties. When the child is of school age, parental concerns often shift to a focus on finding appropriate educational support, helping foster peer relationships, and coping with a variety of medical issues such as non-specific but activity-limiting leg pains, scoliosis, autoimmune diseases, and short stature, at times caused by growth hormone deficiency. Recurrent . {In infancy, visualize palate and evaluate for feeding problems, nasal regurgitation, or both; in toddlers to adults, evaluate nasal speech quality. jjCervical spine films to detect anomalies: anterior/posterior, lateral, extension, open mouth, skull base views. Expert opinion is divided about the advisability of routine radiography. Symptoms of cord compression are an indication for urgent neurological referral. **Motor and speech/language delays are common; rapid referral to early intervention for any delays can help to optimize outcomes.
† †Vigilance for changes in behavior, emotional state, and thinking, including hallucinations and delusions; in teens and adults, assessment would include at-risk behaviors (sexual activity, alcohol/ drug use, etc). zzSee text for details.
infections may affect school attendance; secondary cardiac procedures may be needed as the child grows. Adolescents and young adults may have new onset or recurrence of seizures, treatable psychiatric illness, or both. In adulthood, a noteworthy proportion of individuals find employment and normal social relationships difficult to establish or sustain. Moreover, throughout the lifespan, new syndromerelated local and systemic conditions may present, which can be especially stressful when the underlying link to 22q11DS is not recognized. 36 Clearly, diagnosis at any age significantly changes genetic counseling and patient treatment. 4, 25 Early diagnosis provides the best opportunity for affecting the course of illness and optimizing outcomes. Anticipatory care includes screening for and coordinated management of associated conditions. 4, 24, 25 Available evidence indicates that standard treatments are effective for related problems, from congenital cardiac anomalies to thyroid disease to psychiatric illness. 37 All management strategies should be pursued, however, in the context of the multi-system nature of 22q11DS. Specialty clinics, or socalled ''clinical centers of excellence,'' can, as seen in this case, provide support for both the parents and treating clinicians while facilitating access to peer-support networks. [23] [24] [25] Such clinics also can provide careful monitoring of the possibilities and challenges faced by the patient, allowing for timely interventions as needed. Because of the complexity of 22q11DS in many cases, when geographically and economically feasible, we recommend that all affected individuals be evaluated periodically at a comprehensive care center. However, the availability of 22q11DS specialty clinics is limited. Thus, these guidelines are designed to assist the primary care physician in caring for the patient with a 22q11.2 deletion. 38 recognizing there is a relatively limited literature for this complex condition, particularly for management issues. Consequently, at this relatively early stage in our knowledge, virtually all the evidence for 22q11DS would be levels III or IV (descriptive studies, expert opinions, or both). 43 Thus we have not formally graded the individual recommendations presented.
A draft consensus document stemming from these two steps was refined at the international 22q11DS meeting in Coventry, England, in 2010 with a goal of transcending nationalities, health care system differences, and subspecialty biases. Like all clinical practice guidelines, these initial recommendations will change with time as more data become available. Furthermore, it is likely that some or many clinicians will be unable to perform all the studies or evaluations because of costs, varying patterns of practice, and other reasons. As for most guidelines, there are no data available on cost effectiveness of anticipatory care (eg, identifying and treating hypocalcemia to prevent seizures) in 22q11DS. However, these guidelines, while tending to err on the side of being overly complete, strive to embrace what is collectively considered current best practice, allowing the caregiver to be aware of potential associations that may be clinically significant. Table I presents the multi-system features, including both those that are common and those that are rarer but may be significant for diagnosis, follow-up, or both. 25, 35 
Guidelines Summarized

Genetic Counseling
Genetic counseling for 22q11DS includes a discussion on prevalence, etiology, detection, variability, interventions, and prenatal/preconception options. 4 Some affected adults, especially those detected through their more severely affected child, have been found to have the deletion despite minimal clinical findings. 34 Moreover, somatic mosaicism has been reported. 39 Thus, despite the absence of obvious clinical features, parental studies are always warranted to provide appropriate recurrence risk counseling. Likewise, the occurrence of germ line mosaicism results in a small recurrence risk for parents of children with de novo deletions. 40, 41 Rarely, patients have both a 22q11.2 deletion and another confounding diagnosis, such as a familial single gene disorder or other sporadic cytogenetic abnormality. This can complicate the assessment of features attributable to the 22q11.2 deletion and genetic counseling. Even more rarely the deletion occurs as a result of an unbalanced chromosome translocation, 10 and this too influences the recurrence risk counseling. Thus, the provider must exclude the possibility of a rearrangement before providing counseling.
Affected individuals, regardless of sex and similar to patients with an autosomal dominant condition, have a 50% chance of having an affected child in each pregnancy. In light of the variability of the syndrome, however, it is impossible to predict the range and severity of manifestations in the offspring. Prenatal diagnostic options for such patients include: ultrasound scanning and fetal echocardiography, which is non-invasive but only detect some of the congenital anomalies associated with 22q11DS, prenatal deletion testing, such as via chorionic villus sampling or amniocentesis, which is highly accurate, or both. Preconception options include donor gametes with or without confirmatory prenatal testing or preimplantation genetic diagnosis utilizing in vitro fertilization. 4 Counseling includes up-to-date information on the associated conditions commonly found, conditions likely to develop at the different developmental stages in 22q11DS, or both ( Table I ). In addition, information about management strategies, local resources, and supports should be provided to the patients, their families, and their clinicians.
Ideally, genetic counseling would be repeated at each life stage, with updated information about 22q11DS provided and questions answered. This is particularly important during transition to adolescence and adulthood when reproductive issues and treatable late onset conditions, such as psychiatric illness, are prominent features. 25 
Conclusion
In summary, these guidelines present the best practice recommendations currently available across the lifespan of a patient, with a major focus on the changing issues through childhood development. These guidelines will require updating as new information becomes available. n 
